The themes Quest Diagnostics is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
As participações na receita são estimativas para three months ended June 30, 2026, não números de um relatório oficial.
Routine and non-routine clinical laboratory tests
Tests of blood, urine and other samples, including common checks of blood counts, organ function, allergies and infections, as well as more specialized tests.
Advanced diagnostic tests
Specialized tests in areas such as cancer, genetics, brain health and autoimmune disease. Examples include blood tests for Alzheimer’s disease risk and Haystack testing for signs of remaining or returning cancer.
Anatomic pathology
Examination of tissue and cell samples to help diagnose cancer and other diseases.
Collaborative Lab Solutions
Services that help hospitals manage their laboratories, choose tests, control supply costs and use laboratory data.
QuestHealth.com
A website where people can buy health and wellness tests, with physician review of test orders and the option to discuss results with a physician.
ExamOne
Examinations, sample testing and information gathering that help life insurers assess insurance applicants.
Demonstrações financeiras completas →
Quest Diagnostics collects and tests blood, urine, tissue and other samples, then provides results that help healthcare professionals diagnose, monitor and treat medical conditions. It also performs tests that hospitals send to outside laboratories, helps hospitals run their own labs, and offers testing and data services to insurers and other organizations. It processed 244 million test requisitions (2025, high).
Construído a partir dos próprios documentos de Quest Diagnostics Inc. entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
US$ 259,690,0%fechamento 13 de nov.
Números até 30 de setembro de 2026, do 10-Q arquivado em 23 de outubro de 2026
Quest Diagnostics performs medical tests on blood and other samples for doctors, hospitals, health plans and patients.
Projeção da empresa: receita de de US$ 12,1B a US$ 12,1B para Ano fiscal 2026 — alta de 9,5% em relação ao ano anterior
Grade A
A faixa sob o preço mostra a nota em cada data, calculada só com os documentos já públicos naquele momento.
Mostrando 2 de 40 trimestres do histórico de notas de Quest Diagnostics Inc.. Os outros 38 vão até fevereiro de 2017.